Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters











Database
Language
Publication year range
2.
J Pharm Pharm Sci ; 3(3): 281-91, 2000.
Article in English | MEDLINE | ID: mdl-11177646

ABSTRACT

A study of the appearance of liver apoptosis after ochratoxin A (OTA) administration was performed in male mice. Administration of OTA twice a week for one or two weeks period results in the occurrence of apoptosis in mice"s liver. The presence of intracellular apoptosis bodies was detected at two weeks after toxin treatment. Light microscopic examination demonstrated the presence of eosinophilic globules, often containing apoptotic bodies. They were found within the cytoplasm of intact hepatic cells. The number of apoptotic bodies was further enhanced at two weeks, resulting in 8 fold increases in liver over the control values. No evidence of cell necrosis could be observed by histological and biochemical analysis at one week. However, centrilobular necrosis was evident at two weeks. The ability of the combined antioxidants: Coenzyme Q 10 (CoQ 10), L-carnitine, Zn, Mg, N-acetyl cysteine, vitamin C, vitamin E and selenium or tamoxifen to intervene in apoptosis induced in livers of mice by OTA was also investigated. The inhibition by these scavengers was more clear in mice treated with OTA for one week than those mice treated for two weeks. Treatment with tamoxifen, known in restoration of tumor suppressor function and on induction of programmed cell death (apoptosis), after OTA administration, had no significant inhibition effect on the incidence of apoptotic bodies in liver. Because hepatic glutathione represents the major defence against toxic liver injury, we studied the activity of tissue reduced glutathione (GSH), known to inhibit apoptosis. Our finding showed that two weeks after treatment, OTA caused a decrease of the GSH activity. However, treatment of mice with the combined antioxidants could enhance hepatic antioxidant/detoxification system, as indicated by increase in hepatic reduced glutathione level. In the light of these results, apoptosis was observed after two weeks of OTA administration. We also suggest that use of the combined antioxidants may be of interest in conditions were certain toxin-mediated forms of cell death and/or apoptosis contribute significantly to toxicity.


Subject(s)
Antioxidants/pharmacology , Apoptosis , Liver/drug effects , Ochratoxins/toxicity , Animals , Anticarcinogenic Agents/pharmacology , Carcinogens/toxicity , Drug Interactions , Glutathione/metabolism , Liver/cytology , Liver/metabolism , Male , Mice , Tamoxifen/pharmacology
3.
Pharmacol Res ; 40(6): 459-67, 1999 Dec.
Article in English | MEDLINE | ID: mdl-10660942

ABSTRACT

Active oxygen radical species are reported to cause organ damage. This study was designed to determine whether oxidative stress contributed to the initiation or progression of hepatic and splenic cell DNA damage induced by fumonisin B1 (FB1) in rats. Another aim was to investigate the protective effects of the antioxidants coenzyme Q10 (CoQ10), L-carnitine, vitamin E (alpha-tocopherol) and selenium against DNA damage in the liver and spleen of rats treated with FB1. Fasted rats were injected intravenously with a single dose of fumonisin B1 at 1.55 mg kg-1 body wt. into the tail vein. Treatment with FB1 led to splenic and hepatic DNA fragmentation in 85% of the test animals. DNA fragmentation was investigated as a critical event in toxic cell death by testing total Ca2+ in liver. FB1 administration caused total Ca2+ in liver to increase within 4 h (204% of control). Measurement of liver enzyme activities showed an increase in aspartate aminotransferase (ASAT) and alanine aminotransferase (ALAT). FB1 also markedly decreased splenic and hepatic glutathione (GSH) levels. Pretreatment with CoQ10 (30 mg CoQ10 kg-1 diet) together with L-carnitine (2.8 mg carnitine kg-1 diet), alpha-tocopherol (30 IU vitamin E kg-1 diet) and selenium (1 mg selenium as sodium selenite kg-1 diet), decreased DNA damage and the activities of Ca2+, ASAT and ALAT in the liver. On the other hand, the level of GSH was slightly increased. The CoQ10 alone did not significantly protect against toxic cell death and glutathione depletion caused by FB1. Oxidative damage caused by FB1 may be one of the underlining mechanisms of FB1-induced cell injury and DNA damage.


Subject(s)
Carboxylic Acids/toxicity , Carnitine/pharmacology , DNA Damage , Fumonisins , Liver/drug effects , Selenium/pharmacology , Spleen/drug effects , Ubiquinone/analogs & derivatives , Vitamin E/pharmacology , Animals , Calcium/metabolism , Coenzymes , DNA/drug effects , Glutathione/analysis , Male , Rats , Rats, Sprague-Dawley , Ubiquinone/pharmacology
4.
Vet Microbiol ; 57(2-3): 245-51, 1997 Sep.
Article in English | MEDLINE | ID: mdl-9355259

ABSTRACT

Staphylococcus aureus isolates (N = 40) from bovine mastitis were characterized by random amplified polymorphic DNA-PCR (RAPD-PCR), ribotyping and biotyping. The isolates were collected in the veterinary surveillance area of the Ambulatory Clinic, Faculty of Veterinary Medicine, University of Helsinki from 20 quarters during the acute phase of infection and from the same quarters 3 weeks after cessation of therapy. The aim of the study was to compare the S. aureus isolates taken from the same quarter at different times to verify persistence of virulent strains in infected quarters and to compare the discriminatory power of the diagnostic methods. Using all methods (except for a commercial diagnostic test), the paired isolates of S. aureus were identical. Results suggest that the chronic nature of S. aureus infections was due to the persistence of the original infective strain. More laborious ribotyping and the more convenient RAPD-PCR method produced identical results. The molecular methods differentiated the 40 isolates into 6 distinct genotypes. Biotyping produced partially identical results to RAPD and ribotyping. A commercial diagnostic test system identified only 3 S. aureus biotypes.


Subject(s)
Cattle Diseases , Mastitis, Bovine/microbiology , Random Amplified Polymorphic DNA Technique , Staphylococcal Infections/veterinary , Staphylococcus aureus/isolation & purification , Animals , Bacterial Typing Techniques , Cattle , DNA Primers , Female , Finland , Mastitis, Bovine/epidemiology , Mastitis, Bovine/prevention & control , RNA Probes , Sentinel Surveillance/veterinary , Staphylococcal Infections/epidemiology , Staphylococcal Infections/prevention & control , Staphylococcus aureus/classification , Staphylococcus aureus/growth & development
5.
Mol Aspects Med ; 18 Suppl: S255-8, 1997.
Article in English | MEDLINE | ID: mdl-9266532

ABSTRACT

Active oxygen species are reported to cause organ damage. This study was therefore designed to determine whether oxidative stress contributed to the initiation or progression of hepatic DNA damage produced by T-2 toxin. The aim of the study was also to investigate the behaviour of the antioxidants coenzyme Q10 (CoQ10), and alpha-tocopherol (vitamin E) against DNA damage in the livers of mice fed T-2 toxin. Treatment of fasted mice with a single dose of T-2 toxin (1.8 or 2.8 mg/kg body weight) by oral gavage led to 76% hepatic DNA fragmentation. T-2 toxin also decreased hepatic glutathione (GSH) levels markedly. Pretreatment with CoQ10 (6 mg/kg) together with alpha tocopherol (6 mg/kg) decreased DNA damage. The CoQ10 and vitamin E showed some protection against toxic cell death and glutathione depletion caused by T-2 toxin. Oxidative damage caused by T-2 toxin may be one of the underlying mechanisms for T-2 toxin-induced cell injury and DNA damage, which eventually lead to tumourigenesis.


Subject(s)
Antioxidants/pharmacology , DNA Damage , Liver/drug effects , T-2 Toxin/toxicity , Ubiquinone/analogs & derivatives , Vitamin E/pharmacology , Animals , Antioxidants/administration & dosage , Coenzymes , Glutathione/analysis , Liver/chemistry , Male , Mice , Reactive Oxygen Species , Ubiquinone/administration & dosage , Ubiquinone/pharmacology , Vitamin E/administration & dosage
6.
FEBS Lett ; 275(1-2): 135-8, 1990 Nov 26.
Article in English | MEDLINE | ID: mdl-2261982

ABSTRACT

Site directed mutagenesis has been performed to test hypotheses concerning the putative active sites of Trichoderma reesei cellobiohydrolase I and endoglucanase I. It is shown that mutagenesis of the residue E126, previously proposed to be the proton donor in CBHI, did not totally inactivate the enzyme while mutagenesis of the residue E127 in the homologous enzyme EGI resulted in complete loss of activity. These results are compared with those obtained in similar studies of other glucanases and the effects on enzymatic activity of hyperglycosylation of the yeast produced cellulases are discussed.


Subject(s)
Cellulase/genetics , Glycoside Hydrolases/genetics , Trichoderma/enzymology , Catalysis , Cellulase/metabolism , Cellulose 1,4-beta-Cellobiosidase , Chromatography, Gel , DNA Mutational Analysis , Glycoside Hydrolases/metabolism , Glycosylation , Molecular Weight , Protein Processing, Post-Translational , Recombinant Proteins/metabolism , Structure-Activity Relationship , Trichoderma/genetics
SELECTION OF CITATIONS
SEARCH DETAIL